Q32 Bio Inc. Quarterly Depreciation in USD from Q1 2017 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Q32 Bio Inc. quarterly/annual Depreciation history and growth rate from Q1 2017 to Q1 2024.
  • Q32 Bio Inc. Depreciation for the quarter ending March 31, 2024 was $123K, a 3.15% decline year-over-year.
  • Q32 Bio Inc. Depreciation for the twelve months ending March 31, 2024 was $574K, a 46.5% decline year-over-year.
  • Q32 Bio Inc. annual Depreciation for 2023 was $578K, a 55.3% decline from 2022.
  • Q32 Bio Inc. annual Depreciation for 2022 was $1.29M, a 84.5% decline from 2021.
  • Q32 Bio Inc. annual Depreciation for 2021 was $8.35M, a 4.87% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $574K $123K -$4K -3.15% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $578K $151K -$194K -56.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $772K $100K -$200K -66.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $972K $200K -$100K -33.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $1.07M $127K -$221K -63.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $1.29M $345K -$1.73M -83.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $3.02M $300K -$1.8M -85.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $4.82M $300K -$1.8M -85.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $6.62M $348K -$1.73M -83.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $8.35M $2.07M +$15K +0.73% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 $8.34M $2.1M +$100K +5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $8.24M $2.1M +$100K +5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $8.14M $2.08M +$173K +9.07% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $7.97M $2.06M +$306K +17.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 $7.66M $2M +$300K +17.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $7.36M $2M +$400K +25% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $6.96M $1.91M +$641K +50.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $6.32M $1.75M +$1.18M +208% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 $5.13M $1.7M +$1.4M +467% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $3.73M $1.6M +$1.4M +700% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $2.33M $1.27M +$1.05M +473% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $1.29M $568K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 $300K +$100K +50% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $200K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $221K +$90.8K +69.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q3 2017 $200K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q1 2017 $130K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.